ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in ProQR Therapeutics N.V. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +2 vs. Q4 2023
- Shares held
- 17.4M
- −1.00M (−5.5%) vs. Q4 2023
- Total value
- $39.8M
- +$2.82M (+7.6%) vs. Q4 2023
- New holders
- 4
- 10 more added
- Sold out
- 2
- 15 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRQR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $113.0M |
| Q1 2026 | 69 | $56.8M |
| Q4 2025 | 65 | $75.1M |
| Q3 2025 | 64 | $80.0M |
| Q2 2025 | 62 | $82.4M |
| Q1 2025 | 65 | $54.9M |
| Q4 2024 | 77 | $117.7M |
| Q3 2024 | 47 | $31.7M |
| Q2 2024 | 48 | $28.6M |
| Q1 2024 | 49 | $39.8M |
| Q4 2023 | 47 | $37.0M |
| Q3 2023 | 46 | $24.3M |
| Q2 2023 | 51 | $34.2M |
| Q1 2023 | 55 | $47.5M |
| Q4 2022 | 46 | $60.0M |
| Q3 2022 | 47 | $15.9M |
| Q2 2022 | 51 | $17.2M |
| Q1 2022 | 58 | $28.7M |
| Q4 2021 | 74 | $364.8M |
| Q3 2021 | 67 | $333.4M |
| Q2 2021 | 63 | $259.4M |
| Q1 2021 | 64 | $286.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding ProQR Therapeutics N.V.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 33 | $75 | 0.00% | 00.0% | Unchanged |
| PFS Partners, LLC | 1,000 | $2.29K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,493 | $3.39K | 0.00% | −321−17.7% | Reduced |
| Lazard Asset Management LLC | 4,147 | $9.00K | 0.00% | −1,713−29.2% | Reduced |
| Cutler Group LP | 4,200 | $9.00K | 0.00% | −400−8.7% | Reduced |
| BlackRock Inc. | 3,945 | $9.03K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,970 | $11.4K | 0.00% | +1,070+27.4% | Added |
| Group One Trading, L.P. | 9,690 | $22.0K | 0.00% | −8,716−47.4% | Reduced |
| Vontobel Holding Ltd. | 10,000 | $22.7K | 0.00% | 00.0% | Unchanged |
| Csenge Advisory Group | 10,000 | $22.9K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 10,000 | $22.9K | 0.00% | 00.0% | Unchanged |
| Truist Financial Corp | 10,000 | $22.9K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,996 | $25.2K | 0.00% | 00.0% | Unchanged |
| EP Wealth Advisors, LLC | 11,500 | $26.3K | 0.00% | +11,500 | New |
| Occudo Quantitative Strategies LP | 12,053 | $27.6K | 0.00% | +12,053 | New |
| Advisor Group Holdings, Inc. | 12,811 | $29.1K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 13,550 | $30.0K | 0.00% | +11,756+655.3% | Added |
| Atom Investors LP | 13,107 | $30.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,420 | $39.9K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 18,334 | $42.0K | 0.00% | 00.0% | Unchanged |
| JustInvest LLC | 21,429 | $49.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 23,733 | $54.3K | 0.00% | +13,096+123.1% | Added |
| Acadian Asset Management LLC | 24,763 | $56.0K | 0.00% | +24,763 | New |
| Virtu Financial LLC | 25,943 | $59.0K | 0.00% | −8,961−25.7% | Reduced |
| Bank of Montreal | 30,000 | $73.2K | 0.00% | 00.0% | Unchanged |
| RFG Advisory, LLC | 32,000 | $73.3K | 0.00% | +32,000 | New |
| BNP Paribas Arbitrage, SA | 35,001 | $80.1K | 0.00% | +19,100+120.1% | Added |
| Resources Investment Advisors, LLC. | 45,000 | $103.0K | 0.00% | +13,050+40.8% | Added |
| Citadel Advisors LLC | 46,008 | $104.4K | 0.00% | −31,808−40.9% | Reduced |
| Geode Capital Management, LLC | 46,671 | $105.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 67,591 | $154.8K | 0.00% | −46,120−40.6% | Reduced |
| Two Sigma Investments, LP | 78,944 | $180.8K | 0.00% | −20,547−20.7% | Reduced |
| Boothbay Fund Management, LLC | 106,703 | $244.3K | 0.01% | +10,958+11.4% | Added |
| Bank of America Corp | 110,107 | $252.0K | 0.00% | +31,854+40.7% | Added |
| Susquehanna International Group, LLP | 140,151 | $318.1K | 0.00% | +126,184+903.4% | Added |
| Franklin Street Advisors Inc | 150,000 | $343.0K | 0.03% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 152,502 | $346.2K | 0.00% | +24,328+19.0% | Added |
| Two Sigma Advisers, LP | 162,000 | $371.0K | 0.00% | −6,700−4.0% | Reduced |
| Monaco Asset Management SAM | 312,629 | $709.7K | 0.31% | −65,847−17.4% | Reduced |
| Millennium Management LLC | 328,989 | $746.8K | 0.00% | −120,073−26.7% | Reduced |
| Deutsche Bank AG | 385,149 | $882.0K | 0.00% | −590.0% | Reduced |
| Ikarian Capital, LLC | 483,583 | $1.10M | 0.30% | +10,958+2.3% | Added |
| Macquarie Group Ltd | 620,000 | $1.41M | 0.00% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 905,582 | $2.07M | 0.47% | −35,000−3.7% | Reduced |
| M28 Capital Management LP | 1,019,498 | $2.33M | 1.73% | −891,102−46.6% | Reduced |
| EcoR1 Capital, LLC | 2,884,357 | $6.60M | 0.17% | −95,659−3.2% | Reduced |
| Adage Capital Partners GP, L.L.C. | 3,625,467 | $8.30M | 0.02% | 00.0% | Unchanged |
| Privium Fund Management B.V. | 5,344,446 | $12.2M | 3.27% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −10,085−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,536−100.0% | Sold out |